0001127602-20-031406.txt : 20201215
0001127602-20-031406.hdr.sgml : 20201215
20201215173526
ACCESSION NUMBER: 0001127602-20-031406
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201211
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barnes Alane P
CENTRAL INDEX KEY: 0001584348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 201390568
MAIL ADDRESS:
STREET 1: 1929 BRASSFIELD ROAD
CITY: RALEIGH
STATE: NC
ZIP: 27614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-12-11
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001584348
Barnes Alane P
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior VP, Chief Legal Officer
Common Stock
2020-12-11
4
M
0
13741
4.15
A
121802
D
Common Stock
2020-12-11
4
S
0
13741
7.96
D
108061
D
Emp. Stock Option (Right to Buy)
4.15
2020-12-11
4
M
0
13741
0
D
2012-03-01
2021-03-01
Common Stock
13741
0
D
This transaction was made pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.95 to $7.97. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Alane P. Barnes
2020-12-15